Michael P. Gulseth

868 total citations
27 papers, 680 citations indexed

About

Michael P. Gulseth is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Michael P. Gulseth has authored 27 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 19 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Michael P. Gulseth's work include Venous Thromboembolism Diagnosis and Management (19 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Cardiac Arrhythmias and Treatments (6 papers). Michael P. Gulseth is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (19 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Cardiac Arrhythmias and Treatments (6 papers). Michael P. Gulseth collaborates with scholars based in United States. Michael P. Gulseth's co-authors include William E. Dager, Edith A. Nutescu, John Fanikos, Gloria R. Grice, James C. Lee, Kazuhiko Kido, Piotr Sobieszczyk, Ann K. Wittkowsky, Randall D. Seifert and Ning Wu and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Michael P. Gulseth

27 papers receiving 658 citations

Peers

Michael P. Gulseth

CCM

SURGE

GHP

Judith S. Hurley United States

Darren M. Triller United States

Marisa Battistella Canada

Gail Wygant United States

Erin R. Weeda United States

William J. Spruill United States

David Battleman United States

Candice L. Garwood United States

Abir O. Kanaan United States

Thomas M. Jaeger United States

Judith S. Hurley United States

Michael P. Gulseth

218 ×0.6

CCM

178 ×0.7

69 ×0.6

SURGE

74 ×1.1

GHP

68 ×1.2

Citations per year, relative to Michael P. Gulseth Michael P. Gulseth (= 1×) peers Judith S. Hurley

Countries citing papers authored by Michael P. Gulseth

Since Specialization

Citations

This map shows the geographic impact of Michael P. Gulseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Gulseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Gulseth more than expected).

Fields of papers citing papers by Michael P. Gulseth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Gulseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Gulseth. The network helps show where Michael P. Gulseth may publish in the future.

Co-authorship network of co-authors of Michael P. Gulseth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Gulseth. A scholar is included among the top collaborators of Michael P. Gulseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Gulseth. Michael P. Gulseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dager, William E., et al.. (2022). Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels. Annals of Pharmacotherapy. 56(12). 1289–1298. 4 indexed citations

Triller, Darren M., Allison Burnett, Lina Matta, et al.. (2022). Creation of a novel specialty residency in thrombosis and hemostasis management. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(2). 117–126. 1 indexed citations

Gulseth, Michael P., et al.. (2019). Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents. Journal of Emergency Medicine. 58(2). 217–233. 20 indexed citations

Gulseth, Michael P., et al.. (2019). Use of specific anti-Xa levels in acute kidney injury to transition patients from oral factor Xa inhibitors to i.v. heparin infusion. American Journal of Health-System Pharmacy. 76(8). 505–511. 12 indexed citations

Gulseth, Michael P., et al.. (2017). Successful use of laboratory monitoring to facilitate an invasive procedure for a patient treated with dabigatran. American Journal of Health-System Pharmacy. 74(7). 461–465. 6 indexed citations

Gulseth, Michael P.. (2016). Vitamin K antagonists, direct oral anticoagulants, and the rationale for reversal agents. American Journal of Health-System Pharmacy. 73(10_Supplement_2). s3–s4. 1 indexed citations

Gulseth, Michael P.. (2016). Overview of direct oral anticoagulant therapy reversal. American Journal of Health-System Pharmacy. 73(10_Supplement_2). s5–s13. 11 indexed citations

Nutescu, Edith A., et al.. (2015). Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients. American Journal of Health-System Pharmacy. 72(14). 1188–1194. 10 indexed citations

Chen, Shih‐Yin, Ning Wu, Michael P. Gulseth, et al.. (2013). One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events. Journal of Managed Care Pharmacy. 19(4). 291–301. 50 indexed citations

10.

Gulseth, Michael P., et al.. (2013). Pharmacokinetic and Pharmacodynamic Drug Interactions With New Oral Anticoagulants. Annals of Pharmacotherapy. 47(11). 1478–1487. 87 indexed citations

11.

Smythe, Maureen A., John Fanikos, Michael P. Gulseth, et al.. (2013). Rivaroxaban: Practical Considerations for Ensuring Safety and Efficacy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(11). 1223–1245. 15 indexed citations

12.

Peitz, Gregory, et al.. (2012). High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: A case report and review of laboratory considerations. American Journal of Health-System Pharmacy. 69(6). 490–495. 12 indexed citations

13.

Gulseth, Michael P., Ann K. Wittkowsky, John Fanikos, et al.. (2011). Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(12). 1232–1249. 24 indexed citations

14.

Dobesh, Paul P., Ann K. Wittkowsky, Zachary A. Stacy, et al.. (2009). Key Articles and Guidelines in the Treatment of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(11). 1385–1385. 10 indexed citations

15.

Gulseth, Michael P., Gloria R. Grice, & William E. Dager. (2009). Pharmacogenomics of warfarin: Uncovering a piece of the warfarin mystery. American Journal of Health-System Pharmacy. 66(2). 123–133. 29 indexed citations

16.

Gulseth, Michael P.. (2008). Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism Introduction. Journal of Managed Care Pharmacy. 14(6 Supp A). 2–3. 182 indexed citations

17.

Gulseth, Michael P., Piotr Sobieszczyk, John Fanikos, & Randall D. Seifert. (2008). Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism. Journal of Managed Care Pharmacy. 14(6 Supp A). 1–30. 27 indexed citations

18.

Gulseth, Michael P., et al.. (2008). Rivaroxaban: An oral direct inhibitor of factor Xa. American Journal of Health-System Pharmacy. 65(16). 1520–1529. 72 indexed citations

19.

Gulseth, Michael P., et al.. (2006). Partnerships between colleges of pharmacy and small-to medium-sized hospitals. American Journal of Health-System Pharmacy. 63(6). 581–583. 2 indexed citations

20.

Gulseth, Michael P.. (2005). Ximelagatran: An orally active direct thrombin inhibitor. American Journal of Health-System Pharmacy. 62(14). 1451–1467. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact